Intravascular-catheter-related infections

Lancet

Volumn 351, Issue 9106, 1998, Pages 893-898

  Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL CATHETERIZATION; CATHETER INFECTION; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0032554513     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)10006-X     Document Type: Review

References (40)

1. 1 Maki DG. Infection caused by intravascular devices: pathogenesis, strategies for prevention. Royal Society of Medicine Services Ltd: London, 1991.
2. 2 Raad II, Darouiche RO. Catheter-related septicemia: risk reduction. Infect Med 1996; 13: 807-12; 815-16; 823.
3. 3 Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomised multicenter trial. Am J Med 1988; 85: 307-14.
4. 4 Heiselman D. Nosocomial bloodstream infections in the critically ill. JAMA 1994; 272: 1819-20.
5. 5 Costerton JW, Nickel JC, Ladd TI. Suitable methods for the comparative study of free-living and surface-associated bacterial populations. Bact Nat 1986; 2: 49-84.
6. 6 Calwell DE, Korber DR, Lawrence JR. Imaging of bacterial cells by fluorescence exclusion using scanning confocal laser microscopy. J Microbiol Meth 1992; 15: 249-61.
7. 7 Sheretz RJ, Raad II, Balani A, Koo L, Rand K. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76-82.
8. 8 Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter infection. N Engl J Med 1977; 296: 1305-09.
9. 9 Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalised patients. J Clin Microbiol 1983; 18: 1061-63.
10. 10 Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 1995; 29: 635-45.
11. 11 Deretic V, Schurr MJ, Boucher JC, Martin DW. Conversion of Pseudomonas aeruginosa to mucoldy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol 1994; 176: 2773-80.
12. 12 Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985; 21: 357-60.
13. 13 Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 9: 197-205.
14. 14 Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomised, controlled trial. Ann Intern Med 1997; 127: 257-66.
15. 15 Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis 1990; 9: 869-72.
16. 16 Raad I. CVC-associated fungaemia in cancer patients. Cliniguide Fungal Infect 1995; 6: 5-8.
17. 17 Quillici N, Audibert G, Conroy M-C, et al. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units. Clin Infect Dis 1997; 25: 1066-70.
18. 18 Faubion WC, Wesley JR, Khaldi N, Silva J. Total parenteral nutrition catheter sepsis: impact of the team approach. J Parenteral Enteral Nutr 1986; 10: 10642-45.
19. 19 Maki DG. Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994; 15: 227-30.
20. 20 Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-38.
21. 21 Maki DG, Band JD. A comparative study of polyantitotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70: 739-44.
22. 22 Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae - a randomised controlled trial. J Hosp Infect 1990; 15: 311-21.
23. 23 Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.
24. 24 Andrivet P, Bacquer A, Vu Ngoc C, et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 1994; 18: 199-206.
25. 25 Timsit J-F, Sebille V, Farkas J-C, et al. Effect of subcutaneous tunnelling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276: 1416-20.
26. 26 Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteraemia attributed to luminal colonization of tunnelled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 80: 591-97.
27. 27 Rackoff WR, Weiman J, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127: 147-51.
28. 28 Raad I, Buzaid A, Rhyne J, et al. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25: 149-51.
29. 29 Segura M, Alvarez-Lerma F, Tellado JM, et al. Advances in surgical technique: a clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 1996; 223: 363-69.
30. 30 Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad spectrum activity and efficacy of catheters coated with minocycline and rifampicin. J Infect Dis 1996; 173: 418-24.
31. 31 Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infection: a randomised, double-blind trial. Ann Intern Med 1997; 127: 267-74.
32. 32 Darouiche R, Raad I, Heard S, et al. A prospective, randomized, multicenter clinical trial comparing central venous catheters impregnated with minocycline and rifampin vs chlorhexidine gluconate and silver sulfadiazine. In: Program and abstracts of the 37th Interscience Conference on antimicrobial agents and chemotherapy, Toronto, Ontario, Sept 28-Oct 1, 1997: abstr.
33. 33 Raad I, Davis S, Khan A, Tarrand J, Bodey GP. Catheter removal affects recurrence of catheter-related coagulase-negative staphylococci bacteremia (cRCNSB). Infect Control Hosp Epidemiol 1992; 13: 215-21.
34. 34 Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Rev Infect Dis 1992; 14: 75-82.
35. 35 Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990; 89: 137-41.
36. 36 Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia: minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995; 155: 1161-66.
37. 37 Rose HD. Venous catheter-associated candidemia. Am J Med Sci 1978; 275: 265-69.
38. 38 Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994; 331: 1325-30.
39. 39 Nguyen MH, Peacock JE, Tanner DC, et al. Therapeutic approaches in patients with candidaemia: evaluation in a multicenter, prospective observational study. Arch Intern Med 1995; 155: 2429-35.
40. 40 Elting LS, Bodey GP. Septicaemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990; 60: 196-206.